Cargando…

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma

Ferroptosis is a newly identified cell death mechanism and potential biomarker for hepatocellular carcinoma (HCC) therapy; however, its clinical relevance and underlying mechanism remain unclear. In this study, transcriptome and methylome data from 374 HCC cases were investigated for 41 ferroptosis‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Tuo, Hu, Bingren, Jin, Chen, Tong, Yifan, Zhao, Jungang, Shi, Zhehao, Zhang, Tan, Deng, Liming, Sun, Zhifu, Chen, Gang, Wang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278110/ https://www.ncbi.nlm.nih.gov/pubmed/34085405 http://dx.doi.org/10.1111/jcmm.16666

Ejemplares similares

Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma: Ferroptosis-related gene model for ICC
por: Yao, Xinfei, et al.
Publicado: (2022)

LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination
por: Zhang, Baofu, et al.
Publicado: (2022)

Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022)

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma
por: Chen, Jida, et al.
Publicado: (2022)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma
por: Li, Guanghao, et al.
Publicado: (2022)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Identification of Molecular Subtypes and a Novel Prognostic Model of Sepsis Based on Ferroptosis-Associated Gene Signature
por: Yang, Hang, et al.
Publicado: (2022)

CAFs-derived SCUBE1 promotes malignancy and stemness through the Shh/Gli1 pathway in hepatocellular carcinoma
por: Zhao, Jungang, et al.
Publicado: (2022)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Zhang, Bo, et al.
Publicado: (2022)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma
por: Yang, Xin, et al.
Publicado: (2022)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia
por: Zhu, Kai, et al.
Publicado: (2022)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
por: Xia, Wuzheng, et al.
Publicado: (2022)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma
por: Meng, Jingshu, et al.
Publicado: (2023)

Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
por: Zheng, Yi, et al.
Publicado: (2021)

Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes
por: Duan, Sainan, et al.
Publicado: (2022)

Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases
por: Ma, Qi, et al.
Publicado: (2022)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes
por: Wang, Yue, et al.
Publicado: (2022)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer
por: Chen, WenZheng, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r8t4anf734c53lf5da56cl7g42